LL-37 Peptide — Antimicrobial & Immunomodulatory Research Peptide (UK)

LL-37 is a research-grade peptide widely studied for its antimicrobial, immunomodulatory, and wound-healing properties. In the United Kingdom, LL-37 is utilised in controlled in-vitro and ex-vivo laboratory studies to investigate innate immune responses, pathogen inhibition, tissue repair mechanisms, and peptide-mediated cellular signalling.

Supplied as a lyophilised peptide powder, LL-37 ensures stable handling, accurate dosing, and reproducible experimental results, making it suitable for advanced research in immunology, infectious disease biology, and regenerative medicine.

Key Facts About LL-37 Peptide

Research Uses

• Investigating antimicrobial activity against bacterial and viral pathogens
• Modulation of innate immune system responses
• Wound healing and tissue regeneration pathway studies
• Cellular signalling and immune pathway research
• Comparative studies of peptide activity in infection and tissue repair models

Advantages

• High laboratory-grade purity for reproducible experimental results
• Stable formulation suitable for standard laboratory handling conditions
• Supports a wide range of experimental designs in immunology and microbiology
• Enables precise investigation of antimicrobial and immunomodulatory mechanisms
• Ideal for advanced research in infection control and tissue regeneration biology

Why Choose LL-37 in the UK?

Researchers in the United Kingdom select LL-37 for its reliability, well-characterised structure, and relevance in antimicrobial and immune system research. Its lyophilised form ensures consistent performance in laboratory settings, making it a trusted peptide for studies involving innate immunity, pathogen response, and tissue repair mechanisms.

LL-37 is intended strictly for laboratory and scientific research use only, supporting investigations in immunology, infectious disease biology, and regenerative cellular processes.